Concordia Hospital

Winnipeg, Manitoba R2K 3S8

0 studies enrolling now · 3 studies all time

What they study most

Idiopathic Pulmonary Fibrosis, Lung Diseases, Interstitial

Studies at this site

• Efficacy and Safety of Nintedanib in Patients With Progressive Fibrosing Interstitial Lung Disease (PF-ILD) — Completed
• Nintedanib Twice Daily vs Placebo in Patients Diagnosed With Idiopathic Pulmonary Fibrosis (IPF) — Completed
• Safety, Tolerability and PK of Nintedanib in Combination With Pirfenidone in IPF — Completed